A pilot randomized controlled trial of combined trauma-focused CBT and sertraline for childhood PTSD symptoms

Journal of the American Academy of Child and Adolescent Psychiatry

Volumn 46, Issue 7, 2007, Pages 811-819

  Cohen, Judith A ^a,c   Mannarino, Anthony P ^a   Perel, James M ^b   Staron, Virginia ^a  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

^c Four Allegheny Center   (United States)

Author keywords

Cognitivebehavioral therapy; Posttraumatic stress disorder; Randomized trial; Sertraline

Indexed keywords

PLACEBO; SEROTONIN UPTAKE INHIBITOR; SERTRALINE;

ACCIDENT; ADOLESCENT; ARTICLE; BEHAVIOR THERAPY; CHILD ABUSE; CHILD GLOBAL ASSESSMENT SCALE; CLINICAL ARTICLE; CLINICAL TRIAL; COGNITIVE THERAPY; COMORBIDITY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DOMESTIC VIOLENCE; DRUG DOSE TITRATION; EVIDENCE BASED MEDICINE; FEMALE; HUMAN; MALE; NON INVASIVE MEASUREMENT; POSTTRAUMATIC STRESS DISORDER; PRIORITY JOURNAL; PSYCHOTHERAPY; RANDOMIZED CONTROLLED TRIAL; SCHOOL CHILD; SEXUAL ABUSE; SUICIDE ATTEMPT; TREATMENT OUTCOME;

ADOLESCENT; CHILD; COGNITIVE THERAPY; COMBINED MODALITY THERAPY; FEMALE; HUMANS; MALE; PILOT PROJECTS; SEROTONIN UPTAKE INHIBITORS; SERTRALINE; STRESS DISORDERS, POST-TRAUMATIC; TREATMENT OUTCOME;

EID: 34250864420     PISSN: 08908567     EISSN: None     Source Type: Journal    
DOI: 10.1097/chi.0b013e3180547105     Document Type: Article

References (31)

1. Achenbach TM (1991), Integrative Guide for the 1991 Child Behavior Checklist (CBCL) 4Y18, YSR and TRF Profiles. Burlington: University of Vermont, Department of Psychiatry
2. American Academy of Child and Adolescent Psychiatry (AACAP) (1998), Practice parameters for the assessment and treatment of children and adolescents with depressive disorders. J Am Acad Child Adolesc Psychiatry 37(suppl):635-835
3. Beck AT, Steer RA, Brown GK (1996), Manual for the Beck Depression Inventory II. San Antonio, TX: Psychological Corporation
4. Birmaher B, Khetarpal S, Brent D et al.(1997), The Screen for Child Anxiety Related Emotional Disorders (SCARED): scale construction and psychometric characteristics. J Am Acad Child Adolesc Psychiatry 36:545-554
5. Borenstein M, Rothstein H, Cohen J (1997), Sample Power 1.0 (software). New York: SPSS
6. Brady KT, Pearlstein T, Asnis GM et al. (2000), Double-blind placebo-controlled study of the efficacy and safety of sertraline treatment of posttraumatic stress disorder. JAMA 283:1837-1844
7. Carrion VG, Weems CF, Ray R, Reiss AL (2002), Toward an empirical definition of pediatric PTSD: the phenomenology of PTSD symptoms in youth. J Am Acad Child Adolesc Psychiatry 41:166-173
8. Cohen JA, Berliner L, March JS (2000), Treatment of children and adolescents. In: Effective Treatments for PTSD, Foa EB, Keane TM, Friedman MY, eds. New York: Guilford, pp 106-138
9. Cohen JA, Deblinger E, Mannarino AP, Steer R (2004), A multisite randomized trial for sexually abused children with symptoms of posttraumatic stress disorder. J Am Acad Child Adolesc Psychiatry 43:393-402
10. Cohen JA, Mannarino AP, Deblinger E (2006), Treating Trauma and Traumatic Grief in Children and Adolescents. New York: Guilford
11. Costello EJ, Angold A (1988), Scales to assess child and adolescent depression: checklists, screens, and nets. J Am Acad Child Adolesc Psychiatry 27:726-737
12. Davidson JRT, Malik ML, Sutherland SM (1996), Response characteristics to antidepressants and placebo in posttraumatic stress disorder. Int Clin Psychopharmacol 12:291-296
13. Deblinger E, Heflin AH (1996), Treating Sexually Abused Children and their Non-Offending Parents: A Cognitive Behavioral Approach. Thousand Oaks, CA: Sage
14. Foa EB, Treadwell K, Johnson K, Feeny NC (2001), The Child PTSD Symptom Scale: a preliminary examination of its psychometric properties. J Clin Child Psychol 30:376-384
15. Green B, Shirk S, Hanze D, Wansrath J (1994), The Children's Global Assessment Scale in clinical practice: an empirical evaluation. J Am Acad Child Adolesc Psychiatry 33:1158-1164
16. Griffin LD, Mellon SH (1999), Selective serotonin reuptake inhibitors directly alter activity of neuroteroidogenic enzymes. Proc Natl Acad Sci U S A 96:13512-13517
17. Kaufman J, Birmaher B, Brent DA et al.(1996), Schedule for Affective Disorders and Schizophrenia for School-Aged Children-Present and Lifetime Version (K-SADS-PL): initial reliability and validity data. J Am Acad Child Adolesc Psychiatry 36:980-988
18. Klein RG (1998), Side Effects Form for Children and Adolescents. New York: New York State Psychiatric Institute. Available from rklein@mssm.edu
19. Leon AC (2000), Placebo protects subjects from nonresponse: a paradox of power. Arch Gen Psychiatry 57:329-330
20. Mannarino AP, Cohen JA (1996), Family-related variable and psychological symptom formation in sexually abused girls. J Child Sex Abuse 5:105-119
21. Mannarino AP, Cohen JA, Berman SR (1994), Children's Attributions and Perceptions Scale: a new measure of child sexual abuse-related factors. J Clin Child Psychol 23:204-211
22. Mitka M (2003), FDA alert on antidepressants for youth. JAMA 290:2534
23. Quitkin FM, Klein DF (2000), What conditions are necessary to assess antidepressant efficacy? Arch Gen Psychiatry 57:323-324
24. Saunders BE, Berliner L, Hanson RF (2004), Department of Justice Office of Victims of Crime Treatment Guidelines for Sexually and Physically Abused Children. Available at: www.musc.edu/cvc. Accessed February 7, 2007
25. Schreiber R, Melon C, DeVry J (1998), The role of 5-HT receptor subtypes in the anxiolytic effects of selective serotonin reuptake inhibitors in the rat ultrasonic vocalization test. Psychopharmacology 135:383-391
26. Shaffer D, Gould MS, Brasic J et al. (1983), A Children's Global Assessment Scale (CGAS). Arch Gen Psychiatry 40:1228-1231
27. TF-CBT Web (2005) A Web based learning course for Trauma-Focused Cognitive Behavioral Therapy. Available at: www.musc.edu/tfcbt. Accessed February 23, 2007
28. U.S. Food and Drug Administration (2004), FDA launches a multi-pronged strategy to strengthen safeguards for children treated with antidepressant medications. FDA News: October 15
29. van der Kolk BA, Dreyfuss D, Michaels M et al.(1994), Fluoxetine in posttraumatic stress disorder. J Clin Psychiatry 55:517-522
30. Walker EA, Unutzer J, Rutter C et al. (1999), Costs of health care use by women HMO members with a history of childhood abuse and neglect. Arch Gen Psychiatry 56:609-613
31. Warshaw MG, Fierman E, Pratt D et al. (1993), Quality of life and dissociation in anxiety disordered patients with histories of trauma or PTSD. Am J Psychiatry 150:1512-1516